|
Q3 FY2026
As of Jun 27, 2026
|
Q2 FY2026
As of Mar 28, 2026
|
Q1 FY2026
As of Dec 27, 2025
|
Q4 FY2025
As of Sep 27, 2025
|
Q3 FY2025
As of Jun 28, 2025
|
Q2 FY2025
As of Mar 29, 2025
|
Q1 FY2025
As of Dec 28, 2024
|
Q4 FY2024
As of Sep 28, 2024
|
Q3 FY2024
As of Jun 29, 2024
|
Q2 FY2024
As of Mar 30, 2024
|
Q1 FY2024
As of Dec 30, 2023
|
Q4 FY2023
As of Sep 30, 2023
|
Q3 FY2023
As of Jul 1, 2023
|
Q2 FY2023
As of Apr 1, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Oct 1, 2022
|
Q3 FY2022
As of Jul 2, 2022
|
Q2 FY2022
As of Apr 2, 2022
|
Q1 FY2022
As of Jan 1, 2022
|
Q4 FY2021
As of Oct 2, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts and Other Receivables, Net, Current | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Deferred income tax assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||||
| Deferred revenue and customer advances | ||||||||||||||||||||
| Accrued payroll and related benefits | ||||||||||||||||||||
| Short-term debt, including current portion of long-term debt | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term liabilities: | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total long-term liabilities | ||||||||||||||||||||
| Preferred stock, $0.01 par value, authorized 5,000 shares, none issued and outstanding | ||||||||||||||||||||
| Common stock, $0.01 par value, authorized 166,667 shares; 114,561 and 113,117 shares issued and 53,404 and 53,921 shares outstanding as of September 27, 2025 and September 28, 2024, respectively | ||||||||||||||||||||
| Treasury stock, 61,157 and 59,196 shares as of September 27, 2025 and September 28, 2024, respectively, at cost | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
